|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 1, 1-11, January 2002
6
1 Integrin
Complex during Cellular Morphogenesis


Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Submitted July 17, 2001; Revised October 2, 2001; Accepted October 5, 2001| |
ABSTRACT |
|---|
|
|
|---|
Upon plating on basement membrane Matrigel, NIH3T3 cells formed an
anastomosing network of cord-like structures, inhibitable by
anti-
6
1 integrin antibodies. For NIH3T3 cells transfected with human CD151 protein, the formation of a cord-like network was also
inhibitable by anti-CD151 antibodies. Furthermore, CD151 and
6
1
were physically associated within NIH3T3 cells. On removal of the short
8-amino acid C-terminal CD151 tail (by deletion or exchange), exogenous
CD151 exerted a dominant negative effect, as it almost completely
suppressed
6
1-dependent cell network formation and NIH3T3 cell
spreading on laminin-1 (an
6
1 ligand). Importantly, mutant CD151
retained
6
1 association and did not alter
6
1-mediated cell
adhesion to Matrigel. In conclusion, the CD151-
6
1
integrin complex acts as a functional unit that markedly
influences cellular morphogenesis, with the CD151 tail being of
particular importance in determining the "outside-in" functions of
6
1-integrin that follow ligand engagement. Also, antibodies to
6
1 and CD151 inhibited formation of endothelial cell cord-like networks, thus pointing to possible relevance of CD151-
6
1 complexes during angiogenesis.
| |
INTRODUCTION |
|---|
|
|
|---|
Studies of integrin-dependent adhesion,
migration, and signaling have focused largely on integrin
ligand binding sites (Plow et al., 2000
) and on cytoplasmic
domains (Liu et al., 2000
). Cytoplasmic domain perturbations
alter ligand binding ("inside-out" signaling) and ligand binding
triggers long-range alterations in cytoplasmic domain interactions
("outside-in" signaling). Integrin functions are modulated
also by lateral associations with other transmembrane proteins (Hemler,
1998
; Woods and Couchman, 2000
). As shown here, outside-in signaling
through
6
1 integrin is markedly influenced by its lateral
association with CD151, a transmembrane-4 superfamily (TM4SF,
tetraspanin) protein.
Tetraspanin proteins contain two extracellular loops, four hydrophobic
transmembrane domains, and two short cytoplasmic tails. Tetraspanins
regulate membrane fusion, trafficking, cell motility, and tumor
metastasis (Wright and Tomlinson, 1994
; Maecker et al., 1997
). Tetraspanins form multimolecular complexes with many other transmembrane proteins, including integrins (Hemler et
al., 1996
; Hemler, 1998
). Despite several reports of
tetraspanin-protein complexes, only a few have documented functional
relevance. For example, results from CD81-null mice support the
relevance of CD81-CD19 association (Maecker and Levy, 1997
; Miyazaki
et al., 1997
; Tsitsikov et al., 1997
), CD9
influences the activity of associated HB-EGF (Iwamoto et
al., 1994
), and antibodies to CD81 and CD151 inhibit the functions
of associated integrins (Domanico et al., 1997
;
Yánez-Mó et al., 1998
; Yauch et al.,
1998
; Stipp and Hemler, 2000
). Notably, anti-CD81 and anti-CD151
antibodies inhibited neurite outgrowth only when associated
3
1
integrin was engaged with ligand (Stipp and Hemler, 2000
).
Among tetraspanin complexes, the CD151-
3
1 integrin
complex has unusually high stoichiometry, proximity, and stability. A specific site in CD151's large extracellular loop is required for
3
1 integrin interaction (Yauch et al., 2000
).
CD151 also may use the same site to form complexes with
6
1,
6
4, and other integrins, while influencing cell motility,
hemidesmosome formation, and other functions (Yánez-Mó
et al., 1998
; Fitter et al., 1999
; Sincock
et al., 1999
; Sterk et al., 2000
). However, the
functional roles of CD151-
6 integrin complexes have not
been specifically demonstrated.
We have proposed a "transmembrane linker" model for tetraspanins
(Hemler, 1998
). In this model, tetraspanin extracellular domains link
to integrins, whereas cytoplasmic domains link to intracellular
signaling enzymes such as phosphatidylinositol 4-kinase and PKC
(Hemler, 1998
; Yauch and Hemler, 2000
; Zhang et al., 2001a
, 2001b
). However, the functional relevance of specific tetraspanin cytoplasmic domains has not been shown. Here we demonstrate that the
CD151-
6
1 integrin complex acts as a functional unit
supporting organization of NIH3T3 cells into a network of cord-like
structures when cultured on Matrigel. Although the extracellular
(and/or transmembrane) region of CD151 mediates
6
1
integrin association, the CD151 C terminus is of particular
importance for modulating
6 integrin-dependent functions.
These results provide perhaps the clearest support to date for a
tetraspanin transmembrane linker model in which CD151 links to an
integrin (
6
1), while using its C-terminal tail to link
with intracellular pathways involved in Matrigel morphogenesis and cell spreading.
When plated on basement membrane matrix (Matrigel), collagen, or other
substrates, endothelial cells often form an anastomosing cellular
network, which may be a model for angiogenesis (Vernon and Sage, 1995
).
The Matrigel model may not fully mimic in vivo angiogenesis or
branching morphogenesis, because the network of cord-like cells
contains few if any lumens (Bikfalvi et al., 1991
). However,
advantages of the Matrigel model are that 1) it can show dramatic
morphological changes that reveal useful information about morphogenic
processes; 2) it is somewhat permissive, such that a variety of
nonendothelial cell types may form cord-like networks (Vernon and Sage,
1995
); and 3) in general, three-dimensional models are more
physiological and may often reveal much more than classical
2-dimensional cell culture models. Finally, Matrigel contains an
abundance of laminin-1, thus providing an opportunity to study
functions of
6
1 integrin and associated proteins such as CD151.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture and CD151 Mutants and Transfectants
The NIH3T3 mouse fibroblast cell line was obtained from American
Type Culture Collection (Bethesda, MD) and cultured in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin, and streptomycin. CD151 mutants were generated by recombinant PCR. As a
template we used wild-type human CD151 cDNA, with an HA tag linked to
its C-terminus, ligated into the eukaryotic expression vector
pZeoSV (Invitrogen, San Diego, CA). As shown in Figure 5, the CD151
mutants generated in this study are as follows: 1) CD151-n-A15 (N-terminal cytoplasmic domain
MGEFNEKKTTCGTVCLKYLLFTY of CD151 replaced by the corresponding
METKPVITCLKTLLIIYS from A15); 2) CD151-c-A15 (C-terminal
cytoplasmic domain SLKLEHY of CD151 replaced with FITANQYEMV from A15);
3) CD151-nc-A15 (both N- and C-termini of CD151 replaced by
corresponding domains from A15); 4) CD151-c2-NAG2 (TM4 and
C-terminal tail HLRVIGAVGIGIACVQVFGMIFTCCLYRSLKLEHY of CD151 replaced
by corresponding regions NLLAVGIFGLCTALVQILGLTFAMTMYCQVVKADTYCA from
TM4SF protein NAG-2); and 5) CD151-
c(GFP) (C-terminal
cytoplasmic tail of CD151 LYRSLKLEHY replaced by green fluorescent
protein [GFP] moiety).
For stable expression of CD151 mutants, plasmid DNAs were transfected
into NIH3T3 cells using Lipofectamine (Life Technologies, Bethesda, MD). After 48 h, cells were then cultured in media
containing Zeocin (200 µg/ml; Invitrogen) for selection. After
2 weeks of selection, colonies were pooled, and CD151-positive cells
were sorted by flow cytometry. For double transfectants, human
3
cDNA in eukaryotic expression vector pRcCMV was cotransfected (into NIH3T3 cells) with CD151 mutant plasmid DNA and selected using both
G418 (1 mg/ml; Life Technologies) and Zeocin. A15/TALLA1 plasmid DNA
was kindly provided by Dr. Osamu Yoshie (Kinki University, Osaka,
Japan), subcloned into pRcCMV vector, and selected in G418 after stable
transfection into NIH3T3 cells. To assess cell surface expression,
NIH3T3 transfectants were analyzed by flow cytometry as previously
described (Zhang and Hemler, 1999
). Cells were incubated with negative
control monoclonal antibody (mAb) and specific mAbs and then with
FITC-conjugated goat anti-mouse IgG and were analyzed using a FACScan
flow cytometer (Becton Dickinson, Mountain View, CA). Fluorescence with
negative control mAb was subtracted to give specific mean fluorescence
intensity (MFI) units.
Antibodies and Other Proteins
mAbs used in this study were anti-human CD151 mAbs 5C11
(Yauch et al., 1998
) and 1A5 (Testa et al., 1999
;
provided by Dr. J Testa); anti-human integrin
3 subunit IIF5
(Weitzman et al., 1993
), anti-human CD147 mAb 8G6
(Berditchevski et al., 1997
), anti-human integrin
V subunit mAb P3G8 (Wayner et al., 1991
), anti-mouse CD9
mAb KMC8 (PharMingen, San Diego, CA), anti-mouse integrin
6
subunit mAb GoH3 (PharMingen), anti-mouse CD44 mAb KM114 (PharMingen),
and negative control mAb P3 (Lemke et al., 1978
). A15 mAbs
B2D and A2 M 30.3 were kindly provided by Dr. Osamu Yoshie
(Kinki University, Osaka, Japan) and Dr. F. Lanza (Strasbourg,
France), respectively. The rabbit polyclonal antibody 6843, against
6A integrin cytoplasmic domain, was a gift from Dr.
V. Quaranta (The Scripps Research Institute, La Jolla, CA). Horseradish peroxidase (HRP)-conjugated goat anti-mouse and goat anti-rabbit secondary antibodies (Sigma, St. Louis, MO) were also used.
Matrigel, a solubilized basement membrane matrix extracted from the
Engelbreth-Holm-Swarm (EHS) mouse sarcoma, was purchased from BD
Bioscience (Bedford, MA). Other ECM proteins used in this study were
human plasma fibronectin (Life Technologies), and mouse laminin 1 (Life
Technologies). PDGF-BB was from BD Bioscience, and bFGF was from Roche
Molecular Biochemicals, Indianapolis, IN.
In Vitro Morphogenesis Assay
The spontaneous formation of interconnecting web-like structures by NIH3T3 or HUVEC cells on Matrigel was used to assess morphogenic potential. Matrigel was plated into 24-well plates (0.4 ml/well) and allowed to solidify for 2 h at 37°C. NIH3T3 or HUVEC cells were then seeded into each well at a concentration of 1 × 105 cells/well in a 0.6 ml volume of DMEM. The final concentration of fetal calf serum was 5%. Cells on Matrigel were cultured at 37°C in 10% CO2 and photographed after ~8, 10, or 24 h or 7 d, as indicated. Images were captured using Scion Image 1.60 (Scion Corp.. Frederick, MD) software through a video camera (TM-7AS; PULNiX America, Inc., Sunnyvale, CA) attached to an inverted phase contrast microscope. All results were obtained in at least two independent experiments.
Immunoprecipitation and Western Blot
Immuoprecipitations were carried out as described (Zhang and
Hemler, 1999
). Briefly, NIH3T3 transfectants were lysed in 1% Brij 99 lysis buffer (containing 150 mM NaCl, 25 mM HEPES, 2 mM phenylmethylsulfonylfluoride, 20 µg/ml leupeptin, 20 µg/ml
aprotinin, 2 mM sodium vanadate, and 2 mM sodium fluoride), at 4°C
for 1 h. Lysates were preincubated (2 times) with a combination of
protein A- and protein G-Sepharose beads (Pharmacia Amersham Biotech, Uppsala, Sweden) at 4°C and each time were clarified by
centrifugation at 10,000 rpm centrifugation. Next, mAb preabsorbed
protein A- and protein G-Sepharose beads were incubated with cell
lysate at 4°C overnight. Beads were washed with 1% Brij 99 lysis
buffer three times, dissolved in Laemmli sample buffer and heated at 95°C for 5 min, and then proteins were resolved by 10% SDS-PAGE. After electrophoretic transfer, nitrocellulose membranes (Schleicher & Schuell, Keene, NH) were sequentially blotted with primary antibody and
HRP-conjugated anti-mouse IgG (Sigma) and then visualized with
chemiluminescence reagent (New England Nuclear Life Science, Boston, MA).
DIC Time-lapse Video Microscopy
As described elsewhere (Zhang et al., 2001a
,
2001b
), acid-washed glass coverslips were affixed to a 60-mm Petri
dish, covering a 12-mm hole. Coverslips were coated 2 h at 37°C
with 100 µl Matrigel. Immediately before image acquisition, NIH3T3
transfectants were detached with 2 mM EDTA in PBS, washed once with
PBS, and plated onto coverslips in complete DMEM medium. Image
acquisition was achieved using a Zeiss Axiovert 135 microscope
(Thornwood, NY) with a VS25 shutter controlled by a Uniblitz D122
driver (Vincent Associates, Rochester, NY) and a video camera (TM-7AS;
PULNiX America, Inc.) connected to a Power Macintosh 6500 equipped with a VG-5 frame grabber (Scion Corp., Frederick, MD) through a focusing monitor (PVM-137; Sony Corp., Parkridge, NJ). A macro written for Scion
Image 1.60 (Scion Corp.) controlled the shutter driver and image
acquisition. Images were captured every 5 min for 13 h, as cells
were maintained in a humidified, 37°C, 10% CO2
environment in a custom-built stage incubator. DIC images were obtained
using a Hoffman Modulation Contrast system (Modulation Optics Inc., Greenvale, NY) consisting of a contrast objective, a condenser, and a
contrast control polarizer.
| |
RESULTS |
|---|
|
|
|---|
CD151-
6
1-dependent Network of Cord-like NIH3T3 Cell
Structures on Matrigel
Upon plating on basement membrane Matrigel, NIH3T3 cells assembled
into a network of cord-like structures visible after 8 h (Figure
1A) and 30 h (Figure 1B). The
process began at ~5 h after cell plating, and the cord-like network
pattern sometimes lasted more than 7 days (Figure 1C), depending on the
batch of Matrigel. Typically, 1-1.5 × 105 cells (in area = 2 cm2) were sufficient to yield cord-like
structures, whereas 5 × 104 cells was often
insufficient. Cell network formation was diminished in the absence of
serum but was strongly promoted in the presence of either PDGF-BB (40 ng/ml) or bFGF (40 ng/ml). For time-lapse images of cellular
network formation and accompanying video, see Figure 5A, below.
|
Because a major component of Matrigel is laminin-1, we considered that
integrin
6
1 (
6
4 is not present in NIH3T3 cells) and
associated CD151 may be involved in network formation. Indeed, anti-murine
6 function-blocking mAb GoH3 dramatically inhibited the
8 h (Figure 1A) and 30 h (Figure 1B) formation of cord-like structures by NIH3T3-pZeo mock transfectants. Network formation by
NIH3T3-CD151 wt cells (transfected with wild-type human CD151) was inhibited not only by anti-
6 mAb GoH3 but also by anti-CD151 mAb
1A5 (Figure 1, A and B). Semiquantitative RT-PCR revealed that
transfected human CD151 was present at a level two- to threefold greater than endogenous murine CD151. In the absence of human CD151, mAb 1A5 was not inhibitory (Figure 1, A and B, bottom left panels). In a separate experiment, after 7 d in culture,
NIH3T3-CD151-
3
1 cotransfectants showed again a dramatic
inhibition of cord-like networks by anti-
6 and anti-CD151 antibodies
(Figure 1C). In contrast, antibodies to CD44, to another tetraspanin
protein (CD9), or to
3 integrin had minimal effect after
7 d (Figure 1C) or after 30 h (our unpublished
results), even though each of those molecules was present in
these NIH3T3 cells at a level higher than either endogenous
6
1
integrin or transfected CD151.
As seen elsewhere, CD151 may physically associate with
6
1
integrin (Serru et al., 1999
). To test for
CD151-
6 integrin complex formation in NIH3T3 cells, cells
were lysed, and then human CD151 immunoprecipitates were blotted for
integrin
6 subunit. Levels of
6 associated with human
CD151 (Figure 2, lane d) were comparable to the levels of total detectable
6 (lanes a and c), thus indicating a high stoichiometry interaction. These results are consistent with
human CD151 being more prevalent than endogenous murine CD151 (which
would also be expected to associate with
6 integrin). In a
control experiment, anti-CD151 antibody failed to coimmunoprecipitate
6 from cells that did not contain human CD151 (lane b).
Immunoprecipitation of the A15 tetraspanin protein yielded minimal
associated
6 integrin (lane h), even though both the
6
integrin (lane g) and the A15 molecule (see Figure 4, below)
were well expressed in NIH3T3-A15 transfectants. Exchange of the CD151
C-terminal cytoplasmic tails with the tail of A15 (see Figure 4 below)
did not result in loss of
6 association (lane f). Thus, specificity
for
6 association does not reside in the cytoplasmic tails of CD151.
Importantly, expression of endogenous
6 was not perturbed upon
transfection of mutant or wild-type CD151 (Figure 2, lanes a, c, and e)
and as seen by flow cytometry.
|
CD151 C-terminal Tail Involvement
Next we discovered that the C-terminal tail of CD151 is clearly
involved during CD151-
6
1-dependent network formation. A tail
exchange mutation (CD151-c-A15) caused an almost
complete loss of cellular network formation (Figure
3) without altering integrin
association (see Figure 2 above). In contrast, the N-terminal tail
exchange mutation (CD151-n-A15) had no discernible effect, whereas exchange of both tails (CD151-nc-A15) did again
abolish the cord-like structures. Expression of wt A15 itself had no
effect. To confirm the role of CD151 C-terminal tail of CD151,
additional mutants were generated, including another exchange mutant
(CD151-c-NAG2) and a deletion mutant
(CD151-
c-GFP). Again, CD151-dependent network formation
among NIH3T3 cells was essentially abolished (Figure 3, bottom panels).
Wild-type CD151, A15, and the various mutants were all stably
expressed at comparable levels on the surface of NIH-3T3 cells (Figure
4). Surface expression of the
CD151-
c-GFP mutant was not analyzed by flow cytometry
using FITC-conjugated second antibody (due to excessive GFP
fluorescence) but instead was confirmed by immunoprecipitation (our
unpublished results). Mutant human CD151 molecules were each
present at levels two- to threefold greater than endogenous murine
CD151, as indicated by semiquantitative RT-PCR.
|
|
In a time-lapse video microscopy study, wild-type CD151 transfectants
initially showed a directional migration and alignment of cells. Next,
there was cell-cell contact among aligned cells, and finally the cells
merged into elongated rod-like structures, before condensing into
thicker cellular cables (Figure 5A and attached video). In sharp contrast, CD151-c-A15 cells were relatively motile but showed no directional cell migration and no cell-cell alignment (Figure 5B and attached video).
|
CD151 C-terminal Tail-spreading Functions
We hypothesized that within a functional CD151-
6
1 complex,
effects of CD151 tail mutation should be best seen when
6
1 is
engaged with ligand. To address this, we carried out cell-spreading assays on laminin-1 (to engage
6
1) and on fibronectin (to engage
5
1). As shown in Figure 6A, a high
percentage of all NIH3T3 transfectants showed abundant spreading after
a 30-min incubation on fibronectin. On laminin 1, the majority of mock,
CD151 wild-type, and A15 transfectants were well spread after 30 min,
but the CD151-c-A15 mutant showed severely impaired spreading.
Photographs of representative spread cells are presented in Figure 6B.
Cell spreading on laminin-1 and a coating of Matrigel yielded
comparable results (Figure 6B, bottom row), consistent with laminin-1
being a major component of Matrigel. These results emphasize that
functional effects of CD151 C-terminal domain mutations are obvious
only when the
6
1 integrin is engaged. Previous results
illustrate that CD151 has little effect on integrin-dependent
cell adhesion (Yauch et al., 1998
). Consistent with this,
static cell adhesion to polymerized Matrigel (at levels identical to
that used in morphogenesis experiments) was not markedly different
among NIH3T3 transfectants (mock, wild-type CD151, CD151-c-A15,
wild-type A15). Each transfectant showed ~950-1100 adherent
cells/mm2, corresponding to ~70-81% of 50,000 input cells, in a standard cell adhesion assay (Pujades et
al., 1997
). Consistent with the presence of laminin 1 in the
Matrigel, adhesion of NIH3T3 transfectants was strongly inhibited
(~80%) by anti-
6 integrin antibody GoH3 (our unpublished
results).
|
Perturbation of Endothelial Cell Structures
Early passage HUVEC cells also form a network of cord-like
structures when cultured on Matrigel (Sincock et al., 1999
).
The appearance of these cord-like structures (Figure
7) was partially disrupted by antibodies
to either CD151 (mAb 5C11), or anti-
6 integrin (mAb GoH3).
However, anti-CD147 mAb 8G6 and anti-
V integrin mAb P3G8 had
no obvious effect. These results indicate that CD151-
6
1 complexes in multiple cell types can play a critical role during morphogenesis into cellular networks on Matrigel.
|
| |
DISCUSSION |
|---|
|
|
|---|
The CD151-
6
1 Complex as a Functional Unit
CD151 formed a complex with integrin
6
1 as shown
here in NIH3T3 cells and as shown elsewhere in HUVECs and other cell
types (Fitter et al., 1999
; Serru et al., 1999
;
Sincock et al., 1999
). The specificity of the
CD151-
6
1 interaction is underscored by our failure to observe
A15/Talla1 tetraspanin association with
6
1 integrin.
Elsewhere, the CD151-
6
1 interaction was highly specific and was
similarly retained under conditions in which other
integrin-tetraspanin interactions were disrupted (Serru et al., 1999
).
Although CD151-
6
1 complexes have been demonstrated previously,
their functional relevance had not been demonstrated. Here we show that
the CD151-
6
1 complex is acting as a functional unit because
CD151 C-terminal tail mutation perturbed
6
1-dependent functions
(network formation, cell spreading) only when
6
1 was engaged (on
purified laminin-1 or on Matrigel) and not when a different
integrin (
5
1) was engaged (on fibronectin). Furthermore, antibodies to both CD151 and
6
1 strongly inhibited network
formation by HUVECs (Figure 7), NIH3T3 cells, NIH3T3-
3 cells (Figure
1) and by an immortalized
3-deficient murine kidney epithelial cell line (Wang et al., 1999
; our unpublished results).
In contrast to CD151-
6
1 complexes, CD151-
3
1
complexes did not influence NIH3T3 cell morphogenesis on Matrigel.
Presumably, although the
3
1 integrin may interact with
laminin-1, it may not interact in the same manner or to the same extent
as
6
1. Alternatively, CD151-
3
1 complexes may transmit
different cellular signals, not conducive to network formation. Whereas
anti-CD151 antibodies inhibited
6
1 integrin-dependent
function when cells were plated on laminin-1 (as shown here);
elsewhere, anti-CD151 antibodies inhibited
3
1 functions on
laminin-5 but not on laminin-1 (Stipp and Hemler, 2000
). Thus,
CD151-
6
1 and CD151-
3
1 complexes are functionally distinct.
A New Dimension in Integrin Signaling
It is well established that integrin cytoplasmic domains
play critical roles in determining the functional consequences of ligand binding (Liu et al., 2000
). For example,
integrin
6 cytoplasmic domains can regulate MAP kinase
activation and cell migration (Gimond et al., 1998
; Wei
et al., 1998
). Now we demonstrate that another cytoplasmic
tail, that of CD151, may be just as important for
6 integrin
function as integrin tails themselves. A transmembrane linker
role for tetraspanins has been proposed (Hemler, 1999
) because
extracellular domains of tetraspanin proteins such as CD151 provide
specificity for integrin association, and intracellular domains
may determine association with signaling molecules such as PtdIns 4-K
(Yauch and Hemler, 2000
) and PKC (Zhang et al., 2001a
,
2001b
). Results here support the concept of TM4SF proteins as
transmembrane linkers. First, a distinct region of CD151, likely extracellular and not involving the cytoplasmic tails, is needed for
6
1 integrin association. Second, the CD151 C-terminal
cytoplasmic tail makes an essential contribution to NIH3T3
morphogenesis, as evidenced by tail deletion and two different tail
exchange mutations. Most likely, our CD151 C-terminal tail mutants are having a dominant negative effect on endogenous CD151. While retaining integrin association, they disrupt critical CD151
tail-dependent signaling pathways that complement
6
1
integrin-signaling pathways. Neither integrin
6
1
expression levels or
6
1-dependent cell adhesion were affected by
transfection of either wild-type or mutant CD151 into NIH3T3 cells.
These latter results are in agreement with previous studies showing
that CD151 and other tetraspanin proteins have little or no effect on
cell adhesion (Hemler et al., 1996
; Yauch et al.,
1998
). Thus, our dominant negative CD151 is altering outside-in rather
than inside-out integrin signaling.
Among tetraspanin proteins, there has been little precedent for
cytoplasmic domains having clear functional relevance. Now we
demonstrate that the CD151 C-terminal tail is clearly distinct from the
A15 and NAG2 tails with respect to its influence on cell network
formation. With the CD151 tail having only ~9 residues, it should be
readily feasible to identify the critical individual amino acids in
future studies. It remains to be demonstrated whether the CD151
C-terminal tail may also play a critical role in the functioning of
CD151-
6
4 complexes in hemidesmosomes (Sterk et al.,
2000
) or in CD151-
3
1 complexes during neurite outgrowth (Stipp
et al., 2001
) and in cell migration (Yauch et
al., 1998
).
Formation of Cord-like Networks on Matrigel
Several cell types may form cord-like networks on a variety of
different extracellular matrices (Vernon and Sage, 1995
). Although the
role of integrins (including
6
1) during network formation has been well established (Bauer et al., 1992
; Berdichevsky
et al., 1994
; Davis and Camarillo, 1995
; Vernon and Sage,
1995
; Stahl et al., 1997
; Sun et al., 1998
), a
major role for a tetraspanin protein has not previously been observed.
In a prior study of endothelial cells on Matrigel, anti-CD151 antibody
inhibition effects were more subtle than shown here, perhaps because of
the use of different antibodies (Sincock et al., 1999
).
In several previous studies, formation of cord-like structures on
Matrigel has been seen as an in vitro model of angiogenesis. Indeed,
our antibody inhibition results seen in NIH3T3 cells were confirmed
using HUVECs, thus suggesting that CD151 may contribute to angiogenesis
in particular and to branching morphogenesis in general. For
fibroblasts in particular, a network of cord formation on Matrigel may
be a model also for wound healing and development (Vernon and Sage,
1995
). On Matrigel, cells that exert mechanical traction forces on the
matrix may then align along "matrix guidance pathways" to form
cord-like structures (Davis and Camarillo, 1995
; Vernon and Sage,
1995
).
Our time-lapse video results suggest that CD151-dependent NIH3T3 cell
morphogenesis has at least three phases: cellular alignment due to
tractional forces, cell motility, and cell-cell contact. It remains to
be determined which of these phases is specifically facilitated by
CD151. CD151 could play a key role at cell-cell contact sites
(Yánez-Mó et al., 1998
; Sincock et
al., 1999
). However, because CD151 effects on cell alignment and
migration precede cell-cell contact, that seems unlikely. Instead,
CD151 may promote cell movement, because tetraspanin proteins in
general and CD151 in particular are well established as regulators of cell motility (Hemler et al., 1996
; Maecker et
al., 1997
; Yauch et al., 1998
). Also, CD151 may promote
mechanical traction-related forces. Consistent with this, CD151 tail
mutation abolished cell spreading, another event requiring tractional forces.
In conclusion, our results provide perhaps the best support to date for
a tetraspanin protein (CD151) having a transmembrane linker function.
The extracellular portion associates with the integrin, whereas
the cytoplasmic tail determines the specific consequences of
integrin outside-in signaling (without altering cell adhesion).
We suggest that while
6
1 is interacting with laminin-1,
6
1-associated CD151 is optimally localized to promote cell
alignment with mechanical traction forces, cell motility, cell
spreading, and/or other events needed for NIH3T3 cell morphogenesis into a cellular reticulum. This points to a new functional role for
CD151. Finally, CD151 and
6
1 integrin also play critical roles during endothelial cell morphogenesis, illustrating the generality of our findings.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by National Institutes of Health grants CA86712 and CA42368 (to M.E.H).
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
martin_hemler{at}dfci.harvard.edu.
* Present address: Vascular Biology Center, University of Tennessee Health Science Center, Memphis, TN 38163.
These authors made equal contributions.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.01-10-0481. Article and publication date are found at www.molbiolcell.org/cgi/doi/10.1091/mbc.01-10-0481.
| |
ABBREVIATIONS |
|---|
Abbreviations used: DIC, differential interference contrast; ECM, extracellular matrix; HUVEC, human umbilical vein endothelial cells; TM4SF, transmembrane 4 superfamily.
| |
REFERENCES |
|---|
|
|
|---|
3
1 complexes with EMMPRIN/basigin/OX47/M6.
J. Biol. Chem.
272, 29174-29180.
6A
1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate.
Mol. Biol. Cell
8, 2253-2265.
6A integrin splice variant in vivo: evidence for a specific functional role of
6A in lymphocyte migration but not in heart development [published erratum appears in J. Cell Biol. 1998, 143(5), following 1412].
J. Cell Biol.
143, 253-266.
chain sites that affect cell adhesion and adhesion strengthening without altering soluble ligand binding.
Mol. Biol. Cell
8, 2635-2645.
3
1integrin, and selectively contribute to
3
1-dependent neurite outgrowth.
J. Cell Sci.
113, 1871-1882.
3
1 integrin regulates epithelial cytoskeletal organization.
J. Cell Sci.
112, 2925-2935.
v
3 and
v
5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface.
J. Cell Biol.
113, 919-929.
6 integrin subunit.
J. Biol. Chem.
273, 5903-5907.
3
1 with CD151 provides a major link to phosphatidylinositol 4-kinase and may regulate cell migration.
Mol. Biol. Cell
9, 2751-2765.
3
1 and TM4SF protein CD151.
J. Biol. Chem.
275, 9230-9238.
3
1 integrin localized at endothelial lateral junctions.
J. Cell Biol.
141, 791-804.
3 chain QPSXXE motifs regulates signaling, motility, and cytoskeletal engagement.
Mol. Biol. Cell
12, 351-365.
1 cytoplasmic domain with ICAP-1 protein.
J. Biol. Chem.
274, 11-19.
This article has been cited by other articles:
![]() |
L. Liu, B. He, W. M. Liu, D. Zhou, J. V. Cox, and X. A. Zhang Tetraspanin CD151 Promotes Cell Migration by Regulating Integrin Trafficking J. Biol. Chem., October 26, 2007; 282(43): 31631 - 31642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeda, A. R. Kazarov, C. E. Butterfield, B. D. Hopkins, L. E. Benjamin, A. Kaipainen, and M. E. Hemler Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro Blood, February 15, 2007; 109(4): 1524 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-K. Hong, Y.-J. Jin, H.-J. Byun, D.-I. Jeoung, Y.-M. Kim, and H. Lee Homophilic Interactions of Tetraspanin CD151 Up-regulate Motility and Matrix Metalloproteinase-9 Expression of Human Melanoma Cells through Adhesion-dependent c-Jun Activation Signaling Pathways J. Biol. Chem., August 25, 2006; 281(34): 24279 - 24292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gesierich, I. Berezovskiy, E. Ryschich, and M. Zoller Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029. Cancer Res., July 15, 2006; 66(14): 7083 - 7094. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sala-Valdes, A. Ursa, S. Charrin, E. Rubinstein, M. E. Hemler, F. Sanchez-Madrid, and M. Yanez-Mo EWI-2 and EWI-F Link the Tetraspanin Web to the Actin Cytoskeleton through Their Direct Association with Ezrin-Radixin-Moesin Proteins J. Biol. Chem., July 14, 2006; 281(28): 19665 - 19675. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Winterwood, A. Varzavand, M. N. Meland, L. K. Ashman, and C. S. Stipp A Critical Role for Tetraspanin CD151 in {alpha}3beta1 and {alpha}6beta4 Integrin-dependent Tumor Cell Functions on Laminin-5 Mol. Biol. Cell, June 1, 2006; 17(6): 2707 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ziyyat, E. Rubinstein, F. Monier-Gavelle, V. Barraud, O. Kulski, M. Prenant, C. Boucheix, M. Bomsel, and J.-P. Wolf CD9 controls the formation of clusters that contain tetraspanins and the integrin {alpha}6{beta}1, which are involved in human and mouse gamete fusion J. Cell Sci., February 1, 2006; 119(3): 416 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Davis and D. R. Senger Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization Circ. Res., November 25, 2005; 97(11): 1093 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He, L. Liu, G. A. Cook, S. Grgurevich, L. K. Jennings, and X. A. Zhang Tetraspanin CD82 Attenuates Cellular Morphogenesis through Down-regulating Integrin {alpha}6-Mediated Cell Adhesion J. Biol. Chem., February 4, 2005; 280(5): 3346 - 3354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lammerding, A. R. Kazarov, H. Huang, R. T. Lee, and M. E. Hemler Tetraspanin CD151 regulates {alpha}6{beta}1 integrin adhesion strengthening PNAS, June 24, 2003; 100(13): 7616 - 7621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Gutierrez-Lopez, S. Ovalle, M. Yanez-Mo, N. Sanchez-Sanchez, E. Rubinstein, N. Olmo, M. A. Lizarbe, F. Sanchez-Madrid, and C. Cabanas A Functionally Relevant Conformational Epitope on the CD9 Tetraspanin Depends on the Association with Activated beta 1 Integrin J. Biol. Chem., January 3, 2003; 278(1): 208 - 218. [Abstract] [Full Text] |